Abstract
Over a 2-year period, 17 patients with histologically proven squamous cell carcinoma of the bronchus, assessed as inoperable or incurable on surgical or medical grounds, were treated with palliative radiotherapy and a concurrent 120-h infusion of 5-flurouracil, at a dosage of 1 g/day. The treatment was found to be well tolerated with no major toxicity. The degree of palliation and survival obtained was found to be no different to that of a historical matched control group, treated with radiotherapy alone, with median survival in the two groups of 35 weeks and 42 weeks respectively (log rank test P greater than 0.69). We conclude that although a non-toxic treatment regime, no benefit was obtained by the addition of 5-flurouracil to palliative radiotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
